Fig. 2From: Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasmaHPLC chromatogram of (A) blank plasma (B) mixture of 12.50 µg/mL XIP and VAL in human plasma sampleBack to article page